CLDX Dividend History & Analysis | N/A Yield
CLDX has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Biotechnology
| Symbol | Market Cap USD | Dividend Yield TTM | Yield on Cost 5y |
|---|---|---|---|
| ABBV | 387,093 M | 3.34% | 7.54% |
| AMGN | 198,244 M | 3.21% | 5.93% |
| GILD | 176,133 M | 2.79% | 5.63% |
| HLN | 46,623 M | 1.76% | 2.46% |
| BIM | 13,627 M | 0.74% | 0.75% |
| Symbol | Market Cap USD | Growth Rate | Consistency |
|---|---|---|---|
| BTX | 1,425 M | 134% | 95.6% |
| HLN | 46,623 M | 30.1% | 100% |
| AMGN | 198,244 M | 7.84% | 100% |
| BIM | 13,627 M | 9.76% | 96.0% |
| ABBV | 387,093 M | 5.98% | 100% |
Quality Dividend Peers in Biotechnology
3.21% Yield
2.79% Yield
CLDX Dividend History: as of February 2026
No dividends paid yet.CLDX Dividend FAQ
Celldex Therapeutics (NASDAQ:CLDX) is a U.S.-based biopharma focused on antibody-based therapies for severe inflammatory, allergic, and autoimmune conditions that lack adequate treatment options. Its pipeline centers on two late-stage candidates: Barzolvolimab (CDX-0159), a KIT-targeting monoclonal antibody being evaluated in chronic urticaria, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific antibody that simultaneously blocks thymic stromal lymphopoietin (TSLP) and depletes mast cells via stem-cell factor (SCF) inhibition.
What is the Dividend Yield of CLDX?
As of February 2026, CLDX`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 23.76.Does CLDX pay a dividend?
As of February 2026 CLDX does not pay a dividend.How often does CLDX pay dividends?
Over the last 12 months, CLDX has issued dividend payments.CLDX dividend forecast
Based on historical data, the forecasted dividends per share for CLDX for the next 4 payments are between 0 (+0.0%) and 0 (+0.0%).This suggests the dividend will remain relatively stable.
Will CLDX pay dividends in 2026?
The next Ex-Dividend date for Celldex Therapeutics (CLDX) is currently unknown.What is the next Ex-Dividend Date for CLDX?
The next Ex-Dividend date for Celldex Therapeutics (CLDX) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of CLDX?
CLDX's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of CLDX?
CLDX's 5-Year Yield on Cost is -%. If you bought CLDX's shares at 24.21 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of CLDX?
CLDX Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does CLDX have a good Dividend Yield?
CLDX`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of CLDX?
The Dividend Payout Ratio of CLDX is unknown.What is the Dividend Rating of CLDX?
CLDX`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield
- Annual dividend per share divided by current share price.
- Payout Ratio
- Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
- Payout FCF
- Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
- Growth Rate (CAGR)
- Compound annual growth rate of dividends over the last 5 years.
- Consistency
- Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
- Yield on Cost
- Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
- Streak
- Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
- Dividend Rating
- Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-01-30 14:21